Market Cap 2.42B
Revenue (ttm) 802.80M
Net Income (ttm) 53.51M
EPS (ttm) N/A
PE Ratio 41.51
Forward PE 53.90
Profit Margin 6.67%
Debt to Equity Ratio 0.00
Volume 570,857
Avg Vol 1,081,116
Day's Range N/A - N/A
Shares Out 29.06M
Stochastic %K 15%
Beta 1.14
Analysts Sell
Price Target $111.33

Company Profile

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerv...

Industry: Medical Devices
Sector: Healthcare
Phone: (844) 672-4357
Address:
5500 Wayzata Blvd., Suite 1600, Golden Valley, United States
PrivateProfiteering
PrivateProfiteering Nov. 21 at 4:36 AM
$INSP is currently trading at $83.27, showing a strong bullish sentiment with an RSI of 66.04, indicating it is nearing overbought territory but still has room for upward movement. The price is above both the 30-day MA (80.91) and the 50-day MA (79.7), suggesting a positive trend. The recent high of $97.25 indicates potential resistance, while the low of $70.77 provides a solid support level. For a trade plan, consider entering at $83.50, just above the current close to confirm momentum. Set a stop loss at $79.50 to manage risk. Target the recent high of $97.25 for the first target, which offers a favorable risk-reward ratio. A secondary target could be set at $90, providing a more conservative exit. Overall, the bullish trend supported by the RSI and MAs suggests a positive outlook for $INSP. https://privateprofiteers.com
0 · Reply
Iightning
Iightning Nov. 21 at 2:31 AM
1ightning® Options Trade Alert (Actionable) | Buy $INSP Dec 19 $85 Call | Enter: $6.80 Exit: $9.68 | Profit: 42.33% ROI | https://1ightning.com
0 · Reply
PrivateProfiteering
PrivateProfiteering Nov. 20 at 9:52 AM
$INSP is currently trading at $86.35, showing a strong upward momentum as indicated by an RSI of 60.74, suggesting it is not overbought yet. The price is above both the 30-day MA of 80.14 and the 50-day MA of 79.53, indicating a bullish trend. The recent 60-day high of 97.25 provides a potential resistance level, while the low of 70.77 offers support. Directional bias is bullish due to the price's position relative to the moving averages and the RSI's proximity to the neutral zone. Suggested entry is at $86.50, with a stop loss at $82.00 to manage risk. Target 1 is set at $92.00, near the previous resistance level, and Target 2 at $95.00, just below the 60-day high. This plan capitalizes on the current bullish sentiment while maintaining a disciplined risk management approach. https://privateprofiteers.com
0 · Reply
Iightning
Iightning Nov. 19 at 11:56 PM
1ightning® Options Trade Alert (Actionable) | Buy $INSP Dec 19 $85 Call | Enter: $6.80 Exit: $9.68 | Profit: 42.33% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 8:11 AM
1ightning® Options Trade Alert (Actionable) | Buy $INSP Dec 19 $85 Call | Enter: $6.80 Exit: $9.68 | Profit: 42.33% ROI | https://1ightning.com
0 · Reply
11thestate
11thestate Nov. 18 at 6:42 PM
We’ve already received a lot of questions from investors about $INSP. In the past six months, $INSP has dropped more than 50% — and hasn’t recovered. That’s why we’ve pulled key details from the complaint and put them together for you. Worth a look. #INSP #InspireMedical https://11th.com/cases/insp-investor-suit?utm_source=stocktwits&utm_medium=referral&utm_campaign=case&utm_content=11182025
0 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 18 at 7:08 AM
$INSP Excellent article that nails exactly where INSP stands right now. So if you want to update your INSP knowledge or get acquainted with INSP, this is a must read. https://beyondspx.com/quote/INSP/analysis/inspire-medical-systems-a-new-era-of-growth-fueled-by-inspire-v-and-market-expansion-nyse-insp
0 · Reply
11thestate
11thestate Nov. 14 at 4:41 PM
With all the buzz around $INSP lately, here’s something worth noting: #InspireMedical is already facing an investor lawsuit — covering multiple allegations. We’re not making predictions, but it’s worth a look. Always good to know the full context. https://11th.com/cases/insp-investor-suit?utm_source=stocktwits&utm_medium=referral&utm_campaign=case&utm_content=11142025
0 · Reply
Estimize
Estimize Nov. 12 at 9:00 PM
Wall St is expecting 0.67 EPS for $INSP Q4 [Reporting 02/10 AMC] http://www.estimize.com/intro/insp?chart=historical&metric_name=eps&utm_co
0 · Reply
topstockalerts
topstockalerts Nov. 4 at 7:17 PM
$INSP Is it going higher? Comment below..
0 · Reply
Latest News on INSP
Inspire Medical: Hiccups For The Sleep Business

Aug 23, 2025, 8:56 AM EDT - 3 months ago

Inspire Medical: Hiccups For The Sleep Business


Inspire Medical Stock Strays Off Course Amid Structural Setback

Aug 7, 2025, 12:41 PM EDT - 3 months ago

Inspire Medical Stock Strays Off Course Amid Structural Setback


PrivateProfiteering
PrivateProfiteering Nov. 21 at 4:36 AM
$INSP is currently trading at $83.27, showing a strong bullish sentiment with an RSI of 66.04, indicating it is nearing overbought territory but still has room for upward movement. The price is above both the 30-day MA (80.91) and the 50-day MA (79.7), suggesting a positive trend. The recent high of $97.25 indicates potential resistance, while the low of $70.77 provides a solid support level. For a trade plan, consider entering at $83.50, just above the current close to confirm momentum. Set a stop loss at $79.50 to manage risk. Target the recent high of $97.25 for the first target, which offers a favorable risk-reward ratio. A secondary target could be set at $90, providing a more conservative exit. Overall, the bullish trend supported by the RSI and MAs suggests a positive outlook for $INSP. https://privateprofiteers.com
0 · Reply
Iightning
Iightning Nov. 21 at 2:31 AM
1ightning® Options Trade Alert (Actionable) | Buy $INSP Dec 19 $85 Call | Enter: $6.80 Exit: $9.68 | Profit: 42.33% ROI | https://1ightning.com
0 · Reply
PrivateProfiteering
PrivateProfiteering Nov. 20 at 9:52 AM
$INSP is currently trading at $86.35, showing a strong upward momentum as indicated by an RSI of 60.74, suggesting it is not overbought yet. The price is above both the 30-day MA of 80.14 and the 50-day MA of 79.53, indicating a bullish trend. The recent 60-day high of 97.25 provides a potential resistance level, while the low of 70.77 offers support. Directional bias is bullish due to the price's position relative to the moving averages and the RSI's proximity to the neutral zone. Suggested entry is at $86.50, with a stop loss at $82.00 to manage risk. Target 1 is set at $92.00, near the previous resistance level, and Target 2 at $95.00, just below the 60-day high. This plan capitalizes on the current bullish sentiment while maintaining a disciplined risk management approach. https://privateprofiteers.com
0 · Reply
Iightning
Iightning Nov. 19 at 11:56 PM
1ightning® Options Trade Alert (Actionable) | Buy $INSP Dec 19 $85 Call | Enter: $6.80 Exit: $9.68 | Profit: 42.33% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 8:11 AM
1ightning® Options Trade Alert (Actionable) | Buy $INSP Dec 19 $85 Call | Enter: $6.80 Exit: $9.68 | Profit: 42.33% ROI | https://1ightning.com
0 · Reply
11thestate
11thestate Nov. 18 at 6:42 PM
We’ve already received a lot of questions from investors about $INSP. In the past six months, $INSP has dropped more than 50% — and hasn’t recovered. That’s why we’ve pulled key details from the complaint and put them together for you. Worth a look. #INSP #InspireMedical https://11th.com/cases/insp-investor-suit?utm_source=stocktwits&utm_medium=referral&utm_campaign=case&utm_content=11182025
0 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 18 at 7:08 AM
$INSP Excellent article that nails exactly where INSP stands right now. So if you want to update your INSP knowledge or get acquainted with INSP, this is a must read. https://beyondspx.com/quote/INSP/analysis/inspire-medical-systems-a-new-era-of-growth-fueled-by-inspire-v-and-market-expansion-nyse-insp
0 · Reply
11thestate
11thestate Nov. 14 at 4:41 PM
With all the buzz around $INSP lately, here’s something worth noting: #InspireMedical is already facing an investor lawsuit — covering multiple allegations. We’re not making predictions, but it’s worth a look. Always good to know the full context. https://11th.com/cases/insp-investor-suit?utm_source=stocktwits&utm_medium=referral&utm_campaign=case&utm_content=11142025
0 · Reply
Estimize
Estimize Nov. 12 at 9:00 PM
Wall St is expecting 0.67 EPS for $INSP Q4 [Reporting 02/10 AMC] http://www.estimize.com/intro/insp?chart=historical&metric_name=eps&utm_co
0 · Reply
topstockalerts
topstockalerts Nov. 4 at 7:17 PM
$INSP Is it going higher? Comment below..
0 · Reply
ZacksResearch
ZacksResearch Nov. 4 at 6:50 PM
$INSP beats expectations but struggles with margins — what's next? 🤔 Inspire Medical posted Q3 EPS of 38 cents, defying the Zacks Consensus Estimate of loss of 15 cents, thanks to enhanced market penetration and awareness. However, the company's operating margin took a hit, plunging 275 bps to 4.3%. 📉 Full earnings breakdown here 👉 https://www.zacks.com/stock/news/2784878/insp-stock-gains-following-q3-earnings-beat-gross-margin-expands?cid=sm-stocktwits-2-2784878-body-19414&ADID=SYND_STOCKTWITS_TWEET_2_2784878_BODY_19414
0 · Reply
forprofit12
forprofit12 Nov. 4 at 5:57 PM
$CORT hopefully we can pull an $INSP like movement. This is also way undervalued. Own both. With owning more insp
0 · Reply
ZacksResearch
ZacksResearch Nov. 4 at 5:50 PM
$INSP pops after a strong Q3 earnings beat 🚀 Revenue is climbing, gross margin is expanding, and management just raised full-year EPS guidance — a clean bullish setup backed by execution. Full breakdown on what’s driving the upside 👉 https://www.zacks.com/stock/news/2784878/insp-stock-gains-following-q3-earnings-beat-gross-margin-expands?cid=sm-stocktwits-2-2784878-teaser-19402&ADID=SYND_STOCKTWITS_TWEET_2_2784878_TEASER_19402
0 · Reply
topstockalerts
topstockalerts Nov. 4 at 5:21 PM
$INSP trying to consolidate here..
0 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 4:43 PM
Piper Sandler has adjusted their stance on Inspire Medical Systems ( $INSP ), setting the rating to Overweight with a target price of 150 → 135.
0 · Reply
Tartufo
Tartufo Nov. 4 at 4:36 PM
0 · Reply
CasInvestments
CasInvestments Nov. 4 at 4:35 PM
$INSP lol institutions are lowering price targets after superior earnings because they are mad they didn’t buy in the $70’s
0 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 4:29 PM
RBC Capital has updated their rating for Inspire Medical Systems ( $INSP ) to Outperform with a price target of 125.
0 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 3:45 PM
Truist Securities has updated their rating for Inspire Medical Systems ( $INSP ) to Hold with a price target of 84.
0 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 3:28 PM
JP Morgan updates rating for Inspire Medical Systems ( $INSP ) to Neutral, target set at 110 → 82.
0 · Reply
topstockalerts
topstockalerts Nov. 4 at 1:04 PM
$INSP keep it on your radar..
1 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 12:38 PM
Wells Fargo updates rating for Inspire Medical Systems ( $INSP ) to Overweight, target set at 101 → 90.
0 · Reply